Literature DB >> 11296137

HIV-associated lymphomas.

D J Straus1.   

Abstract

Intermediate and high-grade non-Hodgkin lymphomas (NHL) with a B-cell phenotype are AIDS-defining illnesses. The incidence of systemic NHL is over 100 times increased, primary central nervous system NHL is over 3000 times increased, and Hodgkin's disease is approximately 10 times increased in the HIV-infected population. Unusual extranodal presentations of NHL and Hodgkin's disease are seen in HIV-infected individuals. High-grade histologies are common for both NHL and Hodgkin's disease in the HIV setting. Treatment approaches may be changing with the advent of highly active antiretroviral therapy, which may allow patients to tolerate more intensive treatment.

Entities:  

Mesh:

Year:  2001        PMID: 11296137     DOI: 10.1007/s11912-001-0059-7

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  52 in total

1.  AIDS-associated primary central nervous system lymphoma. Oncology Core Committee, AIDS Clinical Trials Group.

Authors:  G Galetto; A Levine
Journal:  JAMA       Date:  1993-01-06       Impact factor: 56.272

2.  Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid.

Authors:  R Rubio
Journal:  Cancer       Date:  1994-05-01       Impact factor: 6.860

3.  Mitoguazone therapy in patients with refractory or relapsed AIDS-related lymphoma: results from a multicenter phase II trial.

Authors:  A M Levine; A Tulpule; D Tessman; L Kaplan; F Giles; B D Luskey; D T Scadden; D W Northfelt; I Silverberg; J Wernz; B Espina; D Von Hoff
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

4.  Burkitt's lymphoma in adults with and without human immunodeficiency virus infection: a single-institution clinicopathologic study of 75 patients.

Authors:  M Spina; U Tirelli; V Zagonel; A Gloghini; R Volpe; R Babare; L Abbruzzese; R Talamini; E Vaccher; A Carbone
Journal:  Cancer       Date:  1998-02-15       Impact factor: 6.860

5.  Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemia.

Authors:  D J Straus; G Y Wong; J Liu; J Oppenberg; D A Filippa; J W Gold; K Offit; B D Clarkson
Journal:  Am J Med       Date:  1991-03       Impact factor: 4.965

6.  Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection.

Authors:  H J Delecluse; I Anagnostopoulos; F Dallenbach; M Hummel; T Marafioti; U Schneider; D Huhn; A Schmidt-Westhausen; P A Reichart; U Gross; H Stein
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

7.  Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system.

Authors:  P Cinque; M Brytting; L Vago; A Castagna; C Parravicini; N Zanchetta; A D'Arminio Monforte; B Wahren; A Lazzarin; A Linde
Journal:  Lancet       Date:  1993-08-14       Impact factor: 79.321

8.  Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and nonmalignant lesions in AIDS patients.

Authors:  M Lorberboym; F Wallach; L Estok; R E Mosesson; M Sacher; C K Kim; J Machac
Journal:  J Nucl Med       Date:  1998-08       Impact factor: 10.057

9.  Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival.

Authors:  A M Levine; J Sullivan-Halley; M C Pike; M U Rarick; C Loureiro; M Bernstein-Singer; E Willson; R Brynes; J Parker; S Rasheed
Journal:  Cancer       Date:  1991-12-01       Impact factor: 6.860

10.  Effectiveness of methyl-GAG (methylglyoxal-bis[guanylhydrazone]) in patients with advanced malignant lymphoma.

Authors:  R P Warrell; B J Lee; S J Kempin; M J Lacher; D J Straus; C W Young
Journal:  Blood       Date:  1981-06       Impact factor: 22.113

View more
  2 in total

1.  HIV-related NK/T-cell lymphoma in the brain relapsed during intensive chemotherapy but regressed after chemotherapy discontinuation: the importance of maintaining cellular immunity.

Authors:  Yosuke Nagahata; Aiko Kato; Yukihiro Imai; Takayuki Ishikawa
Journal:  Int J Hematol       Date:  2014-06-18       Impact factor: 2.490

2.  Intracranial Hodgkin's lymphoma in an HIV positive patient.

Authors:  Kevin Ramchandar; L H Verhey; Neilank K Jha; N K Murty; William McMillan
Journal:  J Neurooncol       Date:  2008-04-09       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.